A clinical perspective of cystic fibrosis and new genetic findings: Relationship of CFTR mutations to genotype-phenotype manifestations

American Journal of Medical Genetics

Volumn 116, Issue 3, 2003, Pages 262-267

  Kulczycki, Lucas L ^b   Kostuch, Marzena ^a   Bellanti, Joseph A ^b  

^a Poland   (Poland)

^b NONE

Author keywords

Chloride channel; Cystic fibrosis transmembrane conductance regulator (CFTR) gene; Genotype phenotype; F508 mutation

Indexed keywords

CHLORIDE CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENOTYPE; HOMOZYGOTE; HUMAN; INFANT; LUNG DISEASE; MALE; MALE INFERTILITY; MALNUTRITION; PANCREAS DISEASE; PHENOTYPE; POLLUTION; PRIORITY JOURNAL; REVIEW; SMOKING;

BACTERIA (MICROORGANISMS);

EID: 7444251037     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.10886     Document Type: Review

References (42)

1. Anderson MP, Walsh MJ. 1992. Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science 257:1701-1704.
2. Anguiano A, Oates RD, Amos JA, Dean M, Gerrard B, Stewart C, Maher TA, White MB, Milunsky A. 1992. Congential bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA 267:1794-1797.
3. Augarten A, Kerem BS, Yahav Y, Noiman S, Rivlin Y, Tal A, Blau H, Ben-Tur L, Szeinberg A, Kerem E, Gazit E. 1993. Mild cystic fibrosis and normal or borderline sweat test in patients with 3849+10kb C→T mutation. Lancet 342:25-26.
4. Bodian ML. 1952. Fibrocystic disease of the pancreas. A congental disorder of mucus production (mucosis). London: Wm. Heinemann Medical Book Ltd.
5. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63:827-834.
6. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC, Ruiz Romero J, Verlingue C, Claustres M, Nunes V, Ferec C, Estivill X. 1995. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332:1475-1480.
7. Cohn JA. 2000. The diagnosis of CF in patients with non-classical phenotypes. Pediatr Pulmonol 20:89-90.
8. Cystic Fibrosis Genetic Analysis Consortium. 1990. Worldwide survey of the ΔF508 mutation. Report from the Cystic Fibrosis Analysis Consortium (CFGAC). Am J Hum Genet 47:354-359.
9. Cystic Fibrosis Genetic Analysis Consortium. 1994. Population variation of common cystic fibrosis mutations. Hum Mutat 4:167-177.
10. Di Sant'Agnese PA. 1956. Fibrocystic disease of the pancreas, a generalized disease of exocrine glands. JAMA 160:846.
11. Hamosh A, Corev M. 1993. Correlation between genotype and phenotype in patients with cystic fibrosis. N Eng J Med 329:1308-1313.
12. Hamosh A, Rosenstein BJ, Cutting GR. 1992. CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. Hum Mol Genet 1:542-544.
13. Heim RA, Sugarman EA, Allitto BA. 2001. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel. Genet Med 3:168-176.
14. Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, Gorvoy JD, Quittell L, Friedman KJ, Silverman LM, Boucher RC, Knowles MR. 1996. A novel mutation in the cystic fibrisis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Eng J Med 331;974-980.
15. Highsmith WE Jr, Burch LH, Zhou Z, Olsen JC, Strong TV, Smith T, Friedman KJ, Silverman LM, Boucher RC, Collins FS, Knowles MR. 1997. Identification of a splice site mutation (2789-5G-A) associated with small anounts of normal CFTR mRNA and mild cystic fibrosis. Hum Mutat 9:332-338.
16. Howard M, Frizzell RA, Bedwell DM. 1996. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutation. Mat Med 2:467-469.
17. Illek B, Zhang L, Lewis NC, Moss RB, Dong JY, Fischer H. 1999. Defective function of the cystic fibrosis causing mutation G55ID is recovered by genistein. Am J Physiol 277:833-839.
18. Jarvi K. 1996. Male reproductive tract abnormalities and CFTR mutations. Pediatr Pulmonol 13:115-116.
19. Kaplan R, Shwachman H, Perlmutter AD, Rule A, Khaw KT, Holsclaw DS. 1968. Reproductive failure in males with cystic fibrosis. N Eng J Med 279:65-69.
20. Kerem B, Rommens KM, Buchanan D, Mardiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. 1989. Identification of the cystic gene, genetic analysis. Science 245:1073-1080.
21. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, Tsui LC, Durie P. 1990. The relation between genotype and phenotype in cystic fibrosis analysis the common mutation (ΔF508). N Eng J Med 323:1517-1522.
22. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui LC, Durie P. 1992. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 50:1178-1184.
23. Kulczycki LL, Forsyth LM, Bellanti JA. 1998. Infertility in patients with cystic fibrosis: a historical perspective. Pediatr Asthma Allergy Immunol 12:175-182.
24. Marino CR, Gorelick FS. 1992. Scientific advances in cystic fibrosis. Gastroenterology 103:681-693.
25. Marshall E. 2000. Gene therapy on trial. Science 288:951-957.
26. Monaghan KG, Feldman GL, Barbarotto GM, Manje S, Desai TK, Snow K. 2000. Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study. Am J Med Genet 95:361-365.
27. Moss RB. 2001. New approaches to cystic fibrosis. Hosp Pract 36:25-27, 31-32, 35-37.
28. Riordan JR, Rommens JM, Kerem D, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Rsui L. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073.
29. Rommens JM, Iannuzzi MC, Kerem B. Drumm ML, Melmer GD, Dan M, Rozmahel R, Cole JL, Kemmedy D, Hidaka N, Buchwald M, Riordan JR, Tsui LC, Collins FS. 1989. Identification of the cystic fibrosis gene: chromosome jumping and walking. Science 245:1059-1065.
30. Rubenstein RC, Zeitlin PL. 1998. A pilot clinical trial of oral sodium 4-phenylbutyrate (Biphenyl) in delta ΔF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am J Respir Crit Care Med 157:484-490.
31. Sato S, Ward CL, Krouse ME, Wine JJ, Kapito RR. 1996. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 271:635-638.
32. Sheppard DN, Rich DP, Ostedgaard LS, Gregory RJ, Smith AE, Welsh MJ. 1993. Mutations in CFTR associated with mild disease form C1 channels with altered pore properties. Nature 362:160-164.
33. Shwachman H, Kulczycki LL, Mueller HL, Flake CG. 1962. Nasal polyps in patients with cystic fibrosis. Pediatrics 301:389-401.
34. Strong TV, Smit LS, Turpin SV, Cole JL, Hon CT, Markiewicz D, Petty TL, Craig MW, Rosenow EC, Tsui LC, Iannuzzi MC, Knowles MR, Collins FS. 1991. Cystic fibrosis gene mutations in two sisters with mild disease and normal sweat electrolyte levels. N Eng J Med 325:1630-1634.
35. Tsui LC. 2000. Cystic fibrosis mutations database (www.genet.sickids. on.ca) Toronto Hospital for Children.
36. Van der Ven K, Messer L, Van der Ven H, Jevendran RS, Ober C. 1996. Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Hum Reprod II:513-514.
37. Wang X, Movlan B, Leopold D, Kim J, Rubenstein RC, Togias A, Jproud D, Zeitlin PL, Cutting GR. 2000. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 284:1814-1819.
38. Welsh NJ, Smith AE. 1993. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73:1251-1254.
39. Whitcomb DC, Cohn JA, Ulrich CD. 2000. Inherited diseases of the pancreas. Med Clinics N Am 84:517-664.
40. Wine JJ, Kuo E, Hirlock G, Moss R. 2001. Comprehensive mutation screening in a cystic fibrosis center. Pediatrics 107:280-286.
41. Zielenski J. 2000. Genotype and phenotype in cystic fibrosis. Respiration 67:117-183.
42. Zielenski J, Markiewicz D, Lin SP, Huang FY, Yang-Feng TL, Tsui LC. 1995. Skipping of exon 12 as a consequence of a point mutation (1898-5G→T) in the cystic fibrosis transmembrane conductance regulator gene found in a consanguineous Chinese family. Clin Genet 47:124-132.